glp 1 recommendation GLP-1 nausea: How to handle GLP-1s' most common side effect and trans Recommendations for the safe and

BMC Nephrol 14:16

Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease

SLE: systemic lupus erythematosus

Furthermore, combination therapy with prednisone, azathioprine, and NAC was associated with increased mortality and hospitalization, indicating potential risks with polypharmacy [157] (Table 3)

doi: 10.3389/fimmu.2019.01001 538 WhyteARWilliamsCM

Key highlights Tirzepatide is the first dual GLP-1/GIP receptor agonist that offers stronger appetite suppression, improved glycemic control, and provides significantly greater weight loss than single receptor agonists such as semaglutide, liraglutide, and dulaglutide